• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

vernal keratoconjunctivitis - Articles and news items

Vekacia meets primary and secondary endpoints in VKC trial

Industry news / 11 May 2016 / Victoria White, Digital Content Producer

Vekacia demonstrated efficacy and tolerability vs placebo in the treatment of active, severe vernal keratoconjunctivitis (VKC) in paediatric patients…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +